578-33341-89105
1 vaccination
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 970 / OR
- Registered
- 2021-07-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-31
Registered in v-safe
-
2021-07-31
Dose 1 — Janssen/Johnson & Johnson
- 2021-07-31
-
2021-08-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-08-02
- 2021-08-03
- 2021-08-04
- 2021-08-05
- 2021-08-06
- 2021-08-07
- 2021-08-14
- 2021-08-21
- 2021-08-28
- 2021-09-04
- 2021-09-11
- 2021-10-30
- 2022-01-31
-
2022-07-31
Survey response — 12 months, dose 1MedDRA: Perinatal depression, Postpartum anxiety — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Postpartum depression and anxietyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-31 | Janssen/Johnson & Johnson | No |
Free text
Release 12 — 12 months, dose 1
Symptoms: Postpartum depression and anxiety
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Perinatal depression | · | · | ✓ |
| SD | Postpartum anxiety | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release